Home > Financial Ratios > OXYGENTA PHARMACEUTICAL

OXYGENTA PHARMACEUTICAL
Core EBITDA Margin

    Back to All Ratios
OXYGENTA PHARMACEUTICAL is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for OXYGENTA PHARMACEUTICAL
Please provide your vote to see the results

OXYGENTA PHARMACEUTICAL Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -8.91-24.46-22.972.447.39

What is the latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL ?

The latest Core EBITDA Margin ratio of OXYGENTA PHARMACEUTICAL is -8.91 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar2025-8.91
Mar2024-24.46
Mar2023-22.97
Mar20222.44
Mar20217.39

How is Core EBITDA Margin of OXYGENTA PHARMACEUTICAL Trending?

Years Core EBITDA Margin % Change
Mar2025 -8.91
Negative
Mar2024 -24.46
Negative
Mar2023 -22.97
Negative
Mar2022 2.44
-66.98
Mar2021 7.39 -

Other Financial Ratios of OXYGENTA PHARMACEUTICAL


Compare Core EBITDA Margin ratio of peers of OXYGENTA PHARMACEUTICAL

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL ₹204.7 Cr -4.4% -1.6% -40.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,195.0 Cr 0.9% 12.7% 8.2% Stock Analytics
DIVIS LABORATORIES ₹182,993.0 Cr -0.4% 9.7% 11.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,926.0 Cr 0.5% 5.8% 36.5% Stock Analytics
CIPLA ₹113,052.0 Cr -2.7% 13.9% -6.2% Stock Analytics
DR REDDYS LABORATORIES ₹110,333.0 Cr 1.5% 7.3% 8% Stock Analytics


OXYGENTA PHARMACEUTICAL Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
OXYGENTA PHARMACEUTICAL

-4.4%

-1.6%

-40.3%

SENSEX

1%

-4.1%

-7.4%


You may also like the below Video Courses